metformin has been researched along with naringenin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Choi, JS; Jung, HA; Min, BS; Paudel, P; Seong, SH | 1 |
| Belury, MA; Purushotham, A; Tian, M | 1 |
| Balk, B; Bujok, K; Fromm, MF; Glaeser, H; Mandery, K; Schmidt, I | 1 |
| Malefane, TG; Ndwandwe, DE; Nyane, NA; Owira, PMO; Tlaila, TB | 1 |
| Carani Venkatraman, A; Mutlur Krishnamoorthy, R | 1 |
| Latiff, AA; Mardiana, AA; Sahema, ZCT; Santhana, RL; Syed Ahmad Fuad, SB; Zaidun, NH | 1 |
| Essop, MF; Mato Mofo, EP; Owira, PMO | 1 |
| Burade, V; Goswami, S; Pateliya, B | 2 |
| Chai, HC; Chua, KH; Lim, SK; Mahendran, R; Ong, KC | 1 |
| Bader, GN; Gupta, RK; Gupta, S; Jha, RK; Kawale, A; Rashid, R; Sarkar, S; Singh, A; Tripathi, R | 1 |
2 review(s) available for metformin and naringenin
| Article | Year |
|---|---|
Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Type 2; Flavanones; Humans; Hypoglycemic Agents; Metformin | 2017 |
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment.
Topics: Antioxidants; Chalcones; Curcumin; Diterpenes; Diterpenes, Kaurane; Emodin; Epoxy Compounds; Estrogen Antagonists; Flavanones; Humans; Hypoglycemic Agents; Metformin; Phenanthrenes; Plant Extracts; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; Quercetin; Resveratrol | 2021 |
10 other study(ies) available for metformin and naringenin
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Structure-related protein tyrosine phosphatase 1B inhibition by naringenin derivatives.
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavanones; Hep G2 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2017 |
The citrus fruit flavonoid naringenin suppresses hepatic glucose production from Fao hepatoma cells.
Topics: Animals; Dose-Response Relationship, Drug; Flavanones; Glucose; Glucose-6-Phosphatase; Hypoglycemic Agents; Liver; Liver Neoplasms, Experimental; Metformin; Phosphatidylinositol 3-Kinases; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Signal Transduction | 2009 |
Inhibition of hepatic uptake transporters by flavonoids.
Topics: 1-Methyl-4-phenylpyridinium; Apigenin; Atorvastatin; Biological Transport; Flavanones; Flavonoids; Food-Drug Interactions; HEK293 Cells; Hepatocytes; Heptanoic Acids; Humans; Inhibitory Concentration 50; Kaempferols; Liver-Specific Organic Anion Transporter 1; Metformin; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 1; Pyrroles; Quercetin; Rutin; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfobromophthalein; Tritium | 2012 |
Polyphenols activate energy sensing network in insulin resistant models.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Differentiation; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Flavanones; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Metformin; Muscle Fibers, Skeletal; Palmitates; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Polyphenols; Quercetin; Rats; Rats, Wistar; Sirtuin 1 | 2017 |
Effects of naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Synergism; Flavanones; Fructose; Hyperglycemia; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Metformin; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin | 2019 |
Citrus fruit-derived flavonoid naringenin and the expression of hepatic organic cation transporter 1 protein in diabetic rats treated with metformin.
Topics: Animals; Blood Glucose; Citrus; Diabetes Mellitus, Experimental; Flavanones; Flavonoids; Hypoglycemic Agents; Lactic Acid; Liver; Male; Metformin; Organic Cation Transporter 1; Rats; Rats, Sprague-Dawley; Streptozocin | 2020 |
Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Female; Flavanones; Humans; Interleukin-1beta; Male; Metformin; Mice, Inbred BALB C; Mice, Nude; Necrosis; Triple Negative Breast Neoplasms; Troponin I; Tumor Burden; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2021 |
Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Flavanones; Metformin; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Tumor Burden | 2021 |
Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats.
Topics: Androgens; Animals; Disease Models, Animal; Female; Follicular Cyst; Humans; Letrozole; Metformin; Polycystic Ovary Syndrome; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2023 |